Christie Smythe

Editor in Chief

Christie Smythe is Senior Editor at Thinknum Media, focusing on bankruptcy, bad actors and bubbles. Previously, she worked as an assistant managing editor at Fastinform, the Academic Times, and Law360, as U.S. news editor for the Insurance Insider, and as a reporter at Bloomberg News, the Arizona Daily Star and the Cape Cod Times.

Carted raised one of the biggest seed rounds in Australia's history. Then the cofounder ended up with 0% equity.

Mike Angell claims he was muscled out of his share after leaving and joining gaming NFT marketplace Fractal. The incident highlights the perils of noncompete agreements for founders.

Christie Smythe

1.21.22 5:34 PM

Exclusive: Why Black Girls Code’s Kimberly Bryant is fighting back against “toxic” culture claims

The embattled founder of one of Silicon Valley’s most highly-regarded nonprofits says she hopes to be vindicated in an investigation into alleged workplace impropriety.

Christie Smythe

1.20.22 1:40 AM

Exclusive: Why Black Girls Code’s Kimberly Bryant is fighting back against “toxic” culture claims

The embattled founder of one of Silicon Valley’s most highly-regarded nonprofits says she hopes to be vindicated in an investigation into alleged workplace impropriety.

Christie Smythe

1.19.22 9:43 PM

Even funerals aren’t safe from disruption — meet the woman shaking up the $20 billion death industry

Felicia Barlow Clar helps people save money and arrange creative funeral alternatives, such as a “celebration of life” or having ashes shot into the sky as fireworks.

Christie Smythe

1.14.22 7:23 PM

Remote job listings are up 622% from 2020 — maybe your boss is finally getting the hint

Based on data Thinknum tracks, there were 83,600 listings for “virtual” or “remote" positions posted last month. That was up from 11,600 in February 2020.

Christie Smythe , Stella Weng

1.10.22 2:39 PM

A drug that creates mutant Covid? This Stanford researcher tells us why he’s worried about Merck’s molnupiravir

Michael Z. Lin is speaking out against the FDA's emergency use authorization of the Merck antiviral medication, which he says carries dangerous risks and is only marginally effective.

Christie Smythe

1.3.22 9:36 PM